RPG Life Sciences Share Price
2720.20+67.80 (+2.56%)
+14.82% past 1 Year
News
RPG Life Sciences plans more acquisitions to expand API portfolio
Equity
RPGLIFE
RPG Life Sciences unit to acquire Raghava Life Sciences API business
Equity
RPGLIFE
RPG Life Sciences to host analyst and investor meet on September 2
Equity
RPGLIFE
RPG Life Sciences to host analyst and investor meet on August 25
Equity
RPGLIFE
RPGLIFE Q1 EBITDA rises with improved margin performance on yearly basis
Equity
RPGLIFE
RPG Life Sciences reports strong Q1 revenue growth on year-over-year basis
Equity
RPGLIFE
RPG Life Sciences Q1 FY27 net profit rises on year, earnings snapshot
Equity
RPGLIFE
RPG Life Sciences partners Archerchem to launch Naprosyn ES pain drug in India
Equity
RPGLIFE
RPG Life Sciences partners Archerchem Healthcare to launch Naprosyn ES in India
Equity
RPGLIFE
RPG Life Sciences informs about investor conference
Equity
RPGLIFE
RPG Life Sciences Announces Dividend of Rs 24 Per Share in Corporate Results.
Equity
RPGLIFE
RPG Life Sciences Q4 EBITDA Rises 28.6% YoY to Rs 32.80 Crores, Margin Expands to 18.58%
Equity
RPGLIFE
RPG Life Sciences Q4 FY Net Profit Declines 75% YoY to Rs 29.90 Crores
Equity
RPGLIFE
RPG Life Sciences reports Profit after tax of 29.90 Crores, in the March 2026 quarter
Equity
RPGLIFE
RPG Life Sciences informs about investor presentation
Equity
RPGLIFE
RPG Life Sciences Sees Strong January API Performance and Robust Domestic Portfolio per CNBC-TV18.
Equity
RPGLIFE
RPG Life Sciences - Quaterly Results
Equity
RPGLIFE
RPG Life Sciences Q3 EBITDA Declines 19% YoY to Rs 39.80 Crores, Margin Contracts to 22.09%.
Equity
RPGLIFE
RPG Life Sciences Q3 FY2025 Results: Net Profit Surge Amid Revenue Growth
Equity
RPGLIFE
RPG Life Sciences reports Profit after tax of 22.13 Crores, in the December 2025 quarter
Equity
RPGLIFE